ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$3.99
arrow_downward
-0.25%(-0.0100) 1D
Nov 3, 11:12:31 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.02
High
$4.05
Low
$3.99
Mkt. cap
165.97M
Avg. vol.
133.23K
Volume
15.12K
P/E ratio
0.97
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.32
Shares outstanding
41.60M
No. of employees
13
Open
$4.02
High
$4.05
Low
$3.99
Mkt. cap
165.97M
Avg. vol.
133.23K
Volume
15.12K
P/E ratio
0.97
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.32
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
TradingView
·
1 hour ago
Quantum BioPharma (NASDAQ: QNTM) Draws ‘Men’s Fitness’ Spotlight as Unbuzzd Trial Shows Early Promise
Local 3 News
·
1 hour ago
RAW: NYSE: OPENING BELL (TUESDAY)
Bloomberg.com
·
1 hour ago
Goldman’s Molavi Says 60% of S&P 500 Is in Bear Market Territory
Reuters
·
51 minutes ago
S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.